Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B

Zhongguo Zhongyao Zazhi

Volumn 32, Issue 23, 2007, Pages 2468-2470

  Wang, Shao Li ^a   Yao, Nai Li ^a   Lv, Wen Liang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Determination of treatment based in pathogenesis obtained through differentiation of symptoms and signs; Effect; Medicine; Traditional chinese medicine

Indexed keywords

ANTIVIRUS AGENT; HERBACEOUS AGENT; LAMIVUDINE;

ARTICLE; CHINESE MEDICINE; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; HEPATITIS B; HUMAN; PHYTOTHERAPY;

ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY;

EID: 38549135493     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Susan T Goldstein, Zhou F J, Stephen C Hadler, et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact[J]. Int J Epidemiol, 2005, 34(6):1329.
2. Chinese source
3. Chinese source
4. Chinese source
5. Chinese source
6. Chinese source
7. Chinese source
8. Chinese source
9. Chinese source
10. Chinese source
11. Chinese source
12. Chinese source
13. Chinese source
14. Chinese source
15. Chinese source
16. Chinese source
17. Chinese source
18. Chinese source
19. Chinese source
20. Chinese source
21. Chinese source
22. Chinese source
23. Chinese source
24. Chinese source
25. Chinese source
26. Chinese source
27. Chinese source
28. Chinese source
29. Chinese source
30. Chinese source